Dr. Peter Oppelt, M.D.
Claim this profileWashington University School of Medicine
Expert in Squamous Cell Carcinoma
Expert in Skin Cancer
26 reported clinical trials
53 drugs studied
Area of expertise
1Squamous Cell Carcinoma
Global LeaderStage IV
p16 positive
p16 negative
2Skin Cancer
Global LeaderStage IV
p16 positive
p16 negative
Affiliated Hospitals
Clinical Trials Peter Oppelt, M.D. is currently running
Ramucirumab + Pembrolizumab
for Head and Neck Cancer
This is a phase 2 study investigating the efficacy of ramucirumab in combination with pembrolizumab compared to pembrolizumab monotherapy. Ramucirumab is a VEGFR-2 inhibitor believed to potentially enhance the efficacy of PD-1 inhibitors such as pembrolizumab.
Recruiting1 award Phase 217 criteria
MIT-001
for Oral Mucositis Prevention in Head and Neck Cancer Patients
This trial tests MIT-001, a drug that reduces harmful molecules to prevent inflammation, in patients with advanced head and neck cancer undergoing chemoradiotherapy. The goal is to prevent painful mouth sores by protecting cells and blocking inflammation pathways.
Recruiting0 awards Phase 25 criteria
More about Peter Oppelt, M.D.
Clinical Trial Related3 years of experience running clinical trials · Led 26 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Peter Oppelt, M.D. has experience with
- Pembrolizumab
- Nivolumab
- Atezolizumab
- Ramucirumab
- Carboplatin
- Cisplatin
Breakdown of trials Peter Oppelt, M.D. has run
Squamous Cell Carcinoma
Skin Cancer
Head and Neck Squamous Cell Carcinoma
Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Peter Oppelt, M.D. specialize in?
Peter Oppelt, M.D. focuses on Squamous Cell Carcinoma and Skin Cancer. In particular, much of their work with Squamous Cell Carcinoma has involved Stage IV patients, or patients who are p16 positive.
Is Peter Oppelt, M.D. currently recruiting for clinical trials?
Yes, Peter Oppelt, M.D. is currently recruiting for 6 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Peter Oppelt, M.D. has studied deeply?
Yes, Peter Oppelt, M.D. has studied treatments such as Pembrolizumab, Nivolumab, Atezolizumab.
What is the best way to schedule an appointment with Peter Oppelt, M.D.?
Apply for one of the trials that Peter Oppelt, M.D. is conducting.
What is the office address of Peter Oppelt, M.D.?
The office of Peter Oppelt, M.D. is located at: Washington University School of Medicine, Saint Louis, Missouri 63119 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.